A study concluded that inspiratory muscle performance may be improved by specific Inspiratory Muscle Training in patients with Parkinson’s Disease. This improvement is associated with a significant decrease in their perception of dyspnoea (difficult or laboured breathing; shortness of breath)1.
Any condition that prevents normal physical activity can lead to inspiratory muscle weakness, and in addition to asthma and Chronic Obstructive Pulmonary Disease (COPD), Inspiratory Muscle Training (IMT), such as with POWERbreathe, has been found to be helpful for managing other medical conditions, including chronic heart failure, postoperative pulmonary complications and inspiratory stridor.
Specific Inspiratory Muscle Training (IMT) of the muscles we use to breathe, such as with POWERbreathe, has been demonstrated to increase their strength, resistance to fatigue and reduce breathlessness, as well as being helpful in managing medical conditions including:
- Chronic heart failure and heart disease
- Neuromuscular disease
- Parkinson’s disease
- Spinal cord injury
- Sleep apnoea and snoring (Heijdra et al., 1996)
- Exercise-induced paradoxical vocal fold motion
- Muscular dystrophy
- Multiple Sclerosis
- Voice and speech disorders
- Postoperative pulmonary complications
- Restrictive thoracic disease
- Severe chronic pulmonary hypertension
- Inspiratory stridor
- Duchenne muscular dystrophy
- Myasthenia gravis
- Chronic hemodialysis
- Low back pain
“Respiratory muscle training for respiratory deficits in neurodegenerative disorders: A systematic review”
Authors: Alvaro Reyes, PhD; Mel Ziman, PhD; Ken Nosaka, PhD
Background: Studies of respiratory muscle training on central neurodegenerative pathologies have been aimed at improving pulmonary function. However, there is no certainty about the effectiveness of respiratory muscle training in patients affected by these groups of disorders. The purpose of this review was to assess the evidence regarding the efficacy of inspiratory and expiratory muscle training on respiratory function in patients with neurodegenerative disorders of the central nervous system.
Methods: Studies reporting on inspiratory and expiratory muscle training in patients with neurodegenerative diseases were included.
Conclusions: There is some evidence that respiratory muscle training improves a number of respiratory function parameters in patients with Parkinson’s disease and multiple sclerosis; however, the number of studies and their quality are not sufficient to conclude whether inspiratory or expiratory muscle training is effective for improved respiratory function in patients with neurodegenerative disorders of the central nervous system.
The above is a short excerpt from the Abstract published online, so please visit Chest Journal online to read more.